Abstract
The function of ABC transporters in the body is manifold; such as maintenance of homeostasis, effect on multi-drug resistance and their role in tumor initiation & progression. Evidence pointing towards the direct or indirect role of ABC transporter genes in particular; ABCB1 and ABCG2 in cancer genesis is increasing. However, their role in gallbladder cancer is unexplored. Therefore, we investigated the methylation status and expression pattern of ABCB1 and ABCG2in gallbladder carcinogenesis. The methylation and expression study of ABCB1/MDR1 and ABCG2/BCRP was performed in tumour and normal fresh tissue samples collected from 61 histopathologically diagnosed gallbladder cancer patients. The methylation status was analysed by Methylation-Specific PCR and expression was determined by Real-Time PCR and Immunohistochemistry. Hypomethylation of ABCB1 and ABCG2 was found in 44 (72.13%) and 48 (78.6%) cases, respectively. ABCB1 hypomethylation pattern showed association with female patients (p = 0.040) and GradeII tumors (p = 0.036) while, ABCG2 hypomethylation was more frequent in early tumors (T1-T2). The mRNA expression ofABCB1 and ABCG2 was up-regulated in 33 (54.10%) and 41 (67.21%) patients with fold change of 4.7 and 5.5, respectively. The mRNA expression of both genes showed association with Grade II tumours and the increased fold change of ABCG2 was higher in (T1-T2) depth of invasion (p = 0.02) and Stage I–II disease (p = 0.08). The protein expression on IHC was strongly positive for ABCB1/MDR1and ABCG2/BCRP in 32 (52.46%) and 45 (73.77%) patients, respectively. The protein expression in ABCG2 showed association with patients age > 50 years (p = 0.04) and GradeII differentiation (p = 0.07). Interestingly, the hypomethylation of both the genes showed significant correlation with increased expression. ABCB1/MDR1 and ABCG2/BCRP hypomethylation and overexpression could have a potential role in gallbladder cancer tumorigenesis especially in early stages. The epigenetic change might be a plausible factor for altered gene expression of ABCB1 and ABCG2 in gallbladder cancer.
Similar content being viewed by others
Data availability
Enquiries about data availability should be directed to the authors.
References
Dean M, Hamon Y, Chimini G (2001) The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 42:1007–1017
Noguchi K, Katayama K, Sugimoto Y (2014) Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics. Pharmacogenomics Personalized Med 7:53
Diestra JE, Scheffer GL, Català I et al (2002) Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material. J Pathol 198:213–219
Hu CF, Huang YY, Wang YJ, Gao FG (2016) Upregulation of ABCG2 via the PI3K-Akt pathway contributes to acidic microenvironment-induced cisplatin resistance in A549 and LTEP-a-2 lung cancer cells. Oncol Rep 36:455–461
Yao L, Gu J, Mao Y et al (2018) Dynamic quantitative detection of ABC transporter family promoter methylation by MS-HRM for predicting MDR in pancreatic cancer. Oncol Lett 15:5602–5610
Chen Z, Liu F, Ren Q et al (2010) Suppression of ABCG2 inhibits cancer cell proliferation. Int J Cancer 126:841–851
Cederbye CN, Palshof JA, Hansen TP et al (2016) Antibody validation and scoring guidelines for ABCG2 immunohistochemical staining in formalin-fixed paraffin-embedded colon cancer tissue. Sci Rep 6:1–16
Balça-Silva J, Matias D, do Carmo A et al (2019) Cellular and molecular mechanisms of glioblastoma malignancy: implications in resistance and therapeutic strategies. Semin Cancer Biol 58:130–141
Muriithi W, Macharia LW, Heming CP et al (2020) ABC transporters and the hallmarks of cancer: roles in cancer aggressiveness beyond multidrug resistance. Cancer Biol Med 17:253
Meacham CE, Morrison SJ (2013) Tumour heterogeneity and cancer cell plasticity. Nature 501:328–337
Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105–111
Kanthan R, Senger J-L, Ahmed S, Kanthan SC (2015) Gallbladder cancer in the 21st century. J Oncol 2015:1–26
Levy AD, Murakata LA, Rohrmann CA Jr (2001) Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics 21:295–314
Sirohi B, Singh A, Jagannath P, Shrikhande SV (2014) Chemotherapy and targeted therapy for gall bladder cancer. Indian J Surg Oncol 5:134–141
Saluja SS, Nekarakanti PK, Mishra PK et al (2022) Prospective randomized controlled trial comparing adjuvant chemotherapy vs. no chemotherapy for patients with carcinoma of gallbladder undergoing curative resection. J Gastrointest Surg 26:398–407
Mishra PK, Saluja SS, Prithiviraj N et al (2017) Predictors of curative resection and long term survival of gallbladder cancer–a retrospective analysis. Am J Surg 214:278–286
Kattepur AK, Patkar S, Goel M et al (2019) Role of adjuvant chemotherapy in resected T2N0 gall bladder cancer. J Gastrointest Surg 23:2232–2238
Hundal R, Shaffer EA (2014) Gallbladder cancer: epidemiology and outcome. Clin Epidemiol 6:99
Rio DC, Ares M, Hannon GJ, Nilsen TW (2010) Purification of RNA using TRIzol (TRI reagent). Cold Spring Harbor Protocols 2010:pdb-prot5439
Fletcher JI, Williams RT, Henderson MJ et al (2016) ABC transporters as mediators of drug resistance and contributors to cancer cell biology. Drug Resist Updates 26:1–9
Fletcher JI, Haber M, Henderson MJ, Norris MD (2010) ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer 10:147–156
Domenichini A, Adamska A, Falasca M (2019) ABC transporters as cancer drivers: potential functions in cancer development. Biochimica et Biophysica Acta 1863:52–60
Nobili S, Lapucci A, Landini I et al (2020) Role of ATP-binding cassette transporters in cancer initiation and progression. Semin Cancer Biol. 60:72–95
Mhatre S, Wang Z, Nagrani R et al (2017) Common genetic variation and risk of gallbladder cancer in India: a case-control genome-wide association study. Lancet Oncol 18:535–544
Boekstegers F, Marcelain K, Ponce CB et al (2020) ABCB1/4 gallbladder cancer risk variants identified in India also show strong effects in Chileans. Cancer Epidemiol 65:101643
Goldstein LJ, Galski H, Fojo A et al (1989) Expression of multidrug resistance gene in human cancers. JNCI: J Natl Cancer Inst 81:116–124
Goldstein LJ (1996) MDR1 gene expression in solid tumours. Eur J Cancer 32:1039–1050
Wang X, He J, Xu J et al (2014) Afatinib enhances the efficacy of conventional chemotherapeutic agents by eradicating cancer stem–like cellseradication of cancer stem–like cells by afatinib. Can Res 74:4431–4445
Begicevic R-R, Falasca M (2017) ABC transporters in cancer stem cells: beyond chemoresistance. Int J Mol Sci 18:2362
Zappe K, Cichna-Markl M (2020) Aberrant DNA methylation of ABC transporters in cancer. Cells 9:2281
Sharma G, Mirza S, Parshad R et al (2010) CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients. Clin Biochem 43:373–379
Spitzwieser M, Pirker C, Koblmüller B et al (2016) Promoter methylation patterns of ABCB1, ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients. Oncotarget 7:73347
Nakayama M, Wada M, Harada T et al (1998) Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias. Blood J Am Soc Hematol 92:4296–4307
Cruz PM, Mo H, McConathy WJ et al (2013) The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics. Front Pharmacol 4:119
Sharma B, Agnihotri N (2019) Role of cholesterol homeostasis and its efflux pathways in cancer progression. J Steroid Biochem Mol Biol 191:105377
Li Z-M, Wu Z-X, Han B et al (2016) The association between BMI and gallbladder cancer risk: a meta-analysis. Oncotarget 7:43669
Marin JJ, Monte MJ, Macias RI et al (2022) Expression of chemoresistance-associated ABC proteins in hepatobiliary, pancreatic and gastrointestinal cancers. Cancers 14:3524
Pang L, Word B, Xu J et al (2014) ATP-binding cassette genes genotype and expression: a potential association with pancreatic cancer development and chemoresistance? Gastroenterol Res Practice 2014:1–9
Zhang Z, Zhu F, Xiao L et al (2011) Side population cells in human gallbladder cancer cell line GBC-SD regulated by TGF-β-induced epithelial-mesenchymal transition. J Huazhong Univ Sci Technol [Med Sci] 31:749–755
Zhan M, Wang H, Xu S-W et al (2019) Variants in oxidative stress-related genes affect the chemosensitivity through Nrf2-mediated signaling pathway in biliary tract cancer. EBioMedicine 48:143–160
de Azevedo Delou JM, Vignal GM, Índio-do-Brasil V et al (2017) Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosis. Breast Cancer Targets Ther 9:415
Nakano H, Nakamura Y, Soda H et al (2008) Methylation status of breast cancer resistance protein detected by methylation-specific polymerase chain reaction analysis is correlated inversely with its expression in drug-resistant lung cancer cells. Cancer: Interdisc Int J Am Cancer Soc 112:1122–1130
Moon H-H, Kim S-H, Ku J-L (2016) Correlation between the promoter methylation status of ATP-binding cassette sub-family G member 2 and drug sensitivity in colorectal cancer cell lines. Oncol Rep 35:298–306
Aust S, Obrist P, Jaeger W et al (2004) Subcellular localization of the ABCG2 transporter in normal and malignant human gallbladder epithelium. Lab Invest 84:1024–1036
Wang B-L, Zhai H-Y, Chen B-Y et al (2004) Clinical relationship between MDR1 gene and gallbladder cancer. Hepatobiliary Pancreatic Dis Int 3:296–299
Cao L, Duchrow M, Windhövel U et al (1998) Expression of MDR1 mRNA and encoding P-glycoprotein in archival formalin-fixed paraffin-embedded gall bladder cancer tissues. Eur J Cancer 34:1612–1617
Acknowledgements
The authors acknowledge DBT for providing the fund for fellowship and consumables for the research work under the project entitled “Establishment of Central Molecular Lab in GIPMER to study the diagnosis for precision medicine in order to understand the disease process and utilize it as Clinical Research Facility” (Grant no. BT/INF/22/SP33063/2019).
Funding
The authors have not disclosed any funding.
Author information
Authors and Affiliations
Contributions
N, SSS and SAH has designed the study. N and SSS has written the manuscript. N,AKS,AA,AK,RSAS has contributed in the experimental work supervised by SSS and SAH. N and HA has performed IHC supervised and analysed by VVB. N, SSS and PKN has performed the analysis. SSS and SAH has edited the manuscript. All the authors has reviewed the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors have not disclosed any competing interests.
Ethical approval
The study acquired ethical approval from Institutional Ethical Committee Jamia Millia Islamia (Proposal No. 1/10/292/JMI/IEC/2020) and Institute Ethics Committee Maulana Azad Medical College and Associated Hospital, New Delhi (F.1/IEC/MAMC/77/05/2020/No.163).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Nimisha, Saluja, S.S., Sharma, A.K. et al. Molecular aspects of ABCB1 and ABCG2 in Gallbladder cancer and its clinical relevance. Mol Cell Biochem 478, 2379–2394 (2023). https://doi.org/10.1007/s11010-023-04667-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-023-04667-6